ConvaTec Group PLC (CNVVY)
12.92
-0.18
(-1.37%)
USD |
OTCM |
May 21, 10:22
ConvaTec Group Shareholders Equity (Quarterly): 1.693B for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.693B |
| June 30, 2023 | 1.626B |
| December 31, 2022 | 1.610B |
| June 30, 2022 | 1.583B |
| December 31, 2021 | 1.695B |
| June 30, 2021 | 1.711B |
| December 31, 2020 | 1.671B |
| June 30, 2020 | 1.525B |
| Date | Value |
|---|---|
| December 31, 2019 | 1.561B |
| June 30, 2019 | 1.597B |
| December 31, 2018 | 1.617B |
| June 30, 2018 | 1.557B |
| December 31, 2017 | 1.524B |
| June 30, 2017 | 1.365B |
| December 31, 2016 | 1.246B |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
1.525B
Minimum
Jun 2020
1.711B
Maximum
Jun 2021
1.627B
Average
1.618B
Median
Shareholders Equity (Quarterly) Benchmarks
| Adaptimmune Therapeutics PLC | 24.38M |
| Biodexa Pharmaceuticals Plc | 5.959M |
| Verona Pharma PLC | 224.99M |
| NuCana PLC | 18.96M |
| Autolus Therapeutics PLC | 582.03M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 3.714B |
| Total Liabilities (Quarterly) | 2.021B |
| Debt to Equity Ratio | 0.7248 |
| Current Ratio | 1.622 |
| Net Debt Paydown Yield | 0.63% |